Papers
1
Total Citations
8
H-Index
1
About
Dr. Megan Bock is a urologic oncologist whose research focuses on optimizing surgical management for prostate cancer, particularly in low-risk patient populations. Her most-cited work, a 2017 study on the utilization of pelvic lymph node dissection during robot-assisted radical prostatectomy, critically examines the necessity and outcomes of this procedure in men with low-risk disease. This contribution is vital for refining treatment guidelines, helping to reduce overtreatment and associated morbidity without compromising oncologic control. While her citation count is still growing, Dr. Bock’s research addresses a key tension in modern urologic oncology: balancing aggressive surgical staging with the principles of precision medicine and de-escalation. Her work is particularly relevant for trainees and clinicians navigating the nuances of robotic surgery and risk-adapted care. By challenging routine lymph node dissection in low-risk scenarios, she contributes to a more individualized, evidence-based approach that prioritizes patient quality of life. Dr. Bock’s ongoing investigations continue to shape best practices in prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1